Intrinsic Value of S&P & Nasdaq Contact Us

SpringWorks Therapeutics, Inc. SWTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$62.50
+33%

SpringWorks Therapeutics, Inc. (SWTX) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 7 Buy, 4 Hold.

The consensus price target is $62.50 (low: $47.00, high: $78.00), representing an upside of 33% from the current price $46.99.

SWTX Stock — 12-Month Price Forecast

$62.50
▲ +33.01% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for SpringWorks Therapeutics, Inc., the average price target is $62.50, with a high forecast of $78.00, and a low forecast of $47.00.
The average price target represents a +33.01% change from the last price of $46.99.
Highest Price Target
$78.00
Average Price Target
$62.50
Lowest Price Target
$47.00

SWTX Analyst Ratings

Buy
11
Ratings
7 Buy
4 Hold
Based on 11 analysts giving stock ratings to SpringWorks Therapeutics, Inc. in the past 3 months
Rating breakdown
Buy
7 64%
Hold
4 36%
64%
Buy
7 analysts
36%
Hold
4 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message